Detalhe da pesquisa
1.
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
Clin Immunol
; 126(3): 282-90, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18226586